These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29110212)
1. Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy. Dorsey SG Neurotherapeutics; 2018 Jan; 15(1):176-177. PubMed ID: 29110212 [No Abstract] [Full Text] [Related]
2. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial. Bruna J; Videla S; Argyriou AA; Velasco R; Villoria J; Santos C; Nadal C; Cavaletti G; Alberti P; Briani C; Kalofonos HP; Cortinovis D; Sust M; Vaqué A; Klein T; Plata-Salamán C Neurotherapeutics; 2018 Jan; 15(1):178-189. PubMed ID: 28924870 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence. Kawashiri T; Mine K; Kobayashi D; Inoue M; Ushio S; Uchida M; Egashira N; Shimazoe T Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573316 [TBL] [Abstract][Full Text] [Related]
4. The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial. Arslan S; Zorba Bahceli P; İlik Y; Artaç M Eur J Oncol Nurs; 2020 Oct; 48():101827. PubMed ID: 32932009 [TBL] [Abstract][Full Text] [Related]
5. [Oxaliplatin-induced peripheral neuropathy: how to create a barrier?]. Taïb S; Durand J; Brunet I Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():33-37. PubMed ID: 33052091 [No Abstract] [Full Text] [Related]
6. Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population. Zribi A; Nasr SB; Hamdi S; Ayari J; Fendri S; Balti M; Haddaoui A Pan Afr Med J; 2020; 35():83. PubMed ID: 32537086 [TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. Kang L; Tian Y; Xu S; Chen H J Neurol; 2021 Sep; 268(9):3269-3282. PubMed ID: 32474658 [TBL] [Abstract][Full Text] [Related]
8. Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data. Zamami Y; Niimura T; Kawashiri T; Goda M; Naito Y; Fukushima K; Ushio S; Aizawa F; Hamano H; Okada N; Yagi K; Miyata K; Takechi K; Chuma M; Koyama T; Kobayashi D; Shimazoe T; Fujino H; Izawa-Ishizawa Y; Ishizawa K Biomed Pharmacother; 2022 Apr; 148():112744. PubMed ID: 35240525 [TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity. Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186 [TBL] [Abstract][Full Text] [Related]
11. [Roles of TRPA1 in acute peripheral neuropathy characteristically induced by oxaliplatin]. Nakagawa T; Zhao M; Shirakawa H; Kaneko S Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):76-80. PubMed ID: 23391546 [No Abstract] [Full Text] [Related]
12. Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats. Paniagua N; Girón R; Goicoechea C; López-Miranda V; Vela JM; Merlos M; Martín Fontelles MI Eur J Pain; 2017 Jan; 21(1):61-72. PubMed ID: 27341510 [TBL] [Abstract][Full Text] [Related]
13. The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review. Gebremedhn EG; Shortland PJ; Mahns DA BMC Cancer; 2018 Apr; 18(1):410. PubMed ID: 29649985 [TBL] [Abstract][Full Text] [Related]
14. [Evidence from basic studies on mechanisms and treatment drugs for oxaliplatin-induced peripheral neuropathy]. Egashira N; Kawashiri T; Oishi R Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):66-70. PubMed ID: 23391544 [No Abstract] [Full Text] [Related]
15. Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin-induced peripheral neuropathy in Taiwanese patients with colorectal cancer. Hsu SY; Huang WS; Lee SH; Chu TP; Lin YC; Lu CH; Beaton RD; Jane SW Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12976. PubMed ID: 30536809 [TBL] [Abstract][Full Text] [Related]
16. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy]. Ushio S; Kawashiri T; Egashira N Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635 [No Abstract] [Full Text] [Related]